{"filings":[{"id":863237,"accession_number":"0001193125-26-257730","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-06-04T21:08:13+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA Inc. prices €950M senior notes due 2033 at 4.625% for debt refinancing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Subsidiary IQVIA Inc. priced €950M aggregate principal amount of senior notes due 2033.","Notes bear interest at 4.625% per annum, payable semi-annually beginning Dec 15, 2026.","Proceeds to refinance existing indebtedness and pay fees/expenses related to the offering.","Closing expected on or about June 11, 2026, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":835158,"accession_number":"0001193125-26-255635","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-06-03T20:45:12+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA subsidiary to issue €950M senior notes due 2033 to refinance debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["IQVIA Inc. intends to raise €950,000,000 through a private offering of senior notes due 2033.","Proceeds will refinance certain existing indebtedness and pay offering fees and expenses.","Offering is subject to market and customary conditions; not yet closed.","Notes sold only to QIBs in the U.S. under Rule 144A and to non-U.S. investors under Regulation S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93088,"accession_number":"0001193125-26-212463","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA board authorizes additional $2B share repurchase; total authorization reaches $3.2B","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved $2B increase to existing repurchase program, bringing total remaining authorization to $3.217B.","Repurchases may be made in open market, block trades, or privately; no expiration date set.","Management will determine timing and amount based on stock price, corporate requirements, and market conditions.","Program can be modified, suspended, or discontinued at any time without notice.","Company may also repurchase shares outside the program via private transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93087,"accession_number":"0001628280-26-030118","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q1 revenue $4.15B (+8.4% YoY); adj. EPS $2.90; raises FY2026 adj. EPS guidance to $12.65-12.95","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $274M ($1.61 EPS); Adjusted EBITDA $932M (+5.5% YoY).","Commercial Solutions revenue $1,754M (+11.6% reported); R&D Solutions $2,397M (+6.2%).","R&D Solutions backlog $34.2B; net new bookings $2.5B; book-to-bill 1.04x.","Free cash flow $491M (+15% YoY); repurchased $552M of common stock in Q1.","FY2026 revenue reaffirmed $17.15-17.35B; adj. EPS guidance raised to $12.65-12.95."],"consensus_eps_estimate":null,"consensus_eps_actual":1.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":4151000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93086,"accession_number":"0001193125-26-173771","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-04-23T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"IQVIA stockholders approve 2026 equity plan and re-elect directors at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 9 director nominees elected with over 79% votes cast in favor; Ari Bousbib received 138.4M for, 8.6M against.","Advisory say-on-pay passed with ~80% support (118.4M for, 29.4M against).","PricewaterhouseCoopers ratified as auditor for 2026 with 140.9M votes for (90.8% of votes cast).","2026 Incentive and Stock Award Plan approved with ~65% of votes cast in favor (97.0M for, 51.0M against); reserves 17.94M shares.","Stockholder proposal to split Chairman and CEO roles rejected with 36.7M for (24.8% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104417,"accession_number":"0001628280-26-005605","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q4 revenue up 10.3% to $4.36B; adj EPS $3.42, issues FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $4,364M (+10.3% YoY); GAAP EPS $2.99, adj. EPS $3.42 (+9.6% YoY).","R&D Solutions Q4 bookings $2.7B (book-to-bill 1.18x); backlog $32.7B (+5.3% YoY).","Full-year 2026 guidance: revenue $17.15-17.35B, adj. EBITDA $3.975-4.025B, adj. EPS $12.55-12.85.","Segment reorg effective Jan 1, 2026: CSMS folded into TAS (renamed Commercial Solutions); some real-world offerings moved to R&DS.","Q4 share repurchases $212M; full-year $1,244M; $1.769B authorization remaining."],"consensus_eps_estimate":null,"consensus_eps_actual":7.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":16310000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120708,"accession_number":"0001193125-25-312900","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA refinances $2.19B term loans and $2B revolver, cuts USD interest rate, releases Swiss/Japan borrowers","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $2.19B Term A Dollar Loans and $2B Revolving Credit Commitments on December 9, 2025.","Interest rate on USD term loans and revolving loans reduced by eliminating term SOFR credit spread adjustment.","Swiss Subsidiary Borrower and Japanese Borrower released from all obligations; related collateral documents terminated.","Existing €250M Term A Euro Loans refinanced into new euro term loans.","BofA Securities, PNC, JPMorgan, MUFG, TD Securities, Truist, Wells Fargo, HSBC, Citi, Barclays, Goldman Sachs as lead arrangers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120707,"accession_number":"0001193125-25-267053","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Nobel laureate Dr. William G. Kaelin Jr. appointed to IQVIA board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointment effective November 5, 2025.","Kaelin awarded 2019 Nobel Prize in Physiology or Medicine for oxygen-sensing and VHL tumor suppressor work.","Senior physician-scientist at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School.","Also serves on Eli Lilly board and chairs its Science and Technology Committee.","Board determined Kaelin meets NYSE independence standards."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120706,"accession_number":"0001628280-25-046554","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q3 revenue up 5.2% to $4.1B, adj EPS $3.00; reaffirms FY guide","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4,100M (+5.2% YoY); GAAP EPS $1.93, adj EPS $3.00.","R&D Solutions bookings $2.6B (book-to-bill 1.15x); backlog $32.4B (+4.1% YoY).","Operating cash flow $908M; free cash flow $772M (+35% YoY).","FY2025 guide reaffirmed: rev $16.15-16.25B, adj EBITDA $3.775-3.8B, adj EPS $11.85-11.95.","TAS rev $1,631M (+5.0%), R&DS $2,260M (+4.5%), CSMS $209M (+16.1%)."],"consensus_eps_estimate":null,"consensus_eps_actual":4.86,"consensus_revenue_estimate":null,"consensus_revenue_actual":11946000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137300,"accession_number":"0001193125-25-193510","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"IQVIA appoints Michael Fedock as CFO; Ron Bruehlman to retire Feb 28, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Fedock, currently SVP of FP&A, becomes EVP and CFO effective February 28, 2026.","Ron Bruehlman retires as CFO and transitions to Senior Advisor to the CEO.","Fedock's base salary rises to $750,000 with annual cash incentive target of 100% of base salary; eligible for LTI grants.","Fedock has over 25 years in healthcare, including CFO roles at IQVIA Laboratories and R&D Solutions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137299,"accession_number":"0001478242-25-000102","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q2 revenue $4.017B (+5.3% YoY); adj. EPS $2.81; updates FY25 guidance to $11.75-$12.05","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4,017M (+5.3% YoY); GAAP net income $266M ($1.54 diluted EPS); adjusted diluted EPS $2.81.","R&D Solutions backlog $32.1B (+5.1% YoY); Q2 bookings $2.5B (book-to-bill 1.12x); TAS revenue $1,628M (+8.9% YoY).","Repurchased $607M of stock in Q2 ($1.03B year-to-date); $1.98B authorization remaining.","Updates FY25 guidance: revenue $16.1B-$16.3B, adj. EBITDA $3.75B-$3.825B, adj. diluted EPS $11.75-$12.05.","Net leverage 3.61x; operating cash flow $443M; free cash flow $292M."],"consensus_eps_estimate":null,"consensus_eps_actual":2.94,"consensus_revenue_estimate":null,"consensus_revenue_actual":7846000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154614,"accession_number":"0001193125-25-134940","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-06-04T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA issues $2B of 6.250% senior notes due 2032 to repay revolver borrowings","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["IQVIA Inc., wholly owned subsidiary, issued $2B of 6.250% senior notes due June 1, 2032.","Net proceeds to repay existing revolving credit facility borrowings, pay fees, and for general corporate purposes.","Interest payable semi-annually on June 1 and December 1, starting December 1, 2025.","Notes redeemable at make-whole prior to June 1, 2028, then at declining premium from 3.125% to 0.000%.","Notes are unsecured obligations, guaranteed by certain subsidiaries of IQVIA Inc."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154613,"accession_number":"0001193125-25-133449","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA subsidiary prices $2B senior notes at 6.250% due 2032, proceeds to repay revolver","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["IQVIA Inc. issues $2,000,000,000 in senior notes due 2032 bearing 6.250% annual interest.","Proceeds will repay existing revolving credit facility borrowings and cover fees and expenses.","Notes mature June 1, 2032; interest paid semi-annually on June 1 and December 1, starting Dec 1, 2025.","Closing expected on or about June 4, 2025, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154612,"accession_number":"0001478242-25-000082","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q1 revenue $3,829M, adjusted EPS $2.70 (+6.3%); raises FY revenue guidance on FX","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $249M ($1.40 EPS); adjusted EBITDA $883M (+2.4% YoY).","R&D Solutions backlog $31.5B (+4.8% YoY); quarterly book-to-bill 1.02x, TTM book-to-bill 1.14x.","TAS revenue $1,546M (+6.4% reported, +7.6% constant currency); CSMS revenue $181M (-4.2%).","Operating cash flow $568M, free cash flow $426M (+13% YoY); repurchased $425M of stock.","FY 2025 revenue guidance raised $275M to $16.0-16.4B on FX; profit guidance reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":1.4,"consensus_revenue_estimate":null,"consensus_revenue_actual":3829000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154611,"accession_number":"0001193125-25-093687","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-04-24T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"IQVIA stockholders approve charter amendment for officer exculpation, elect directors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stockholders approved amendment to certificate of incorporation to exculpate officers to fullest extent under Delaware law and remove classified board provisions.","All nine director nominees elected with majority support; Todd B. Sisitsky received 131.7M for, 20.6M against.","Advisory vote on 2024 executive compensation passed with 125.6M for, 26.2M against.","Stockholder proposal on special meetings failed with 66.2M for, 86.0M against.","PricewaterhouseCoopers ratified as independent auditor for 2025 with 145.6M for, 14.7M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173143,"accession_number":"0001193125-25-050927","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA refinances $1.985B term loans, cuts B-4 rate 25 bps, repays Euro loans","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.985B new Term B-5 Dollar Loans issued to refinance Term B-4 Dollar Loans and repay Term B-2 Euro Loans.","Interest rate on Term B-4 Dollar Loans reduced from SOFR+2.00% to SOFR+1.75% per annum.","JPMorgan Chase provided additional incremental Term B-5 commitment of ~$680.7M.","Amendment effective March 10, 2025; proceeds also used for general corporate purposes and fees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173142,"accession_number":"0001478242-25-000016","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q4 adj EPS $3.12 (+9.9% YoY), backlog $31.1B; reaffirms FY25 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $3,958M (+3.0% cc), GAAP EPS $2.42, adj EPS $3.12; FY revenue $15,405M.","FY adjusted EPS $11.13 (+9.1%), free cash flow $2,114M (+41%), operating cash flow $2,716M (+26%).","R&D Solutions backlog $31.1B (+5.5% cc), Q4 book-to-bill 1.20x; TAS revenue +9.5% cc.","Board added $2B to buyback authorization, total remaining $3.013B; $1.35B repurchased in 2024.","Reaffirms FY2025 guidance: revenue $15.725B-$16.125B, adj EBITDA $3.765B-$3.885B, adj EPS $11.70-$12.10."],"consensus_eps_estimate":null,"consensus_eps_actual":7.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":15405000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190168,"accession_number":"0001478242-24-000113","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q3 revenue $3,896M, Adj EPS $2.84 (+14.1%); FY24 guidance cut on trial delays","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $3,896M (+4.3% YoY); GAAP EPS $1.55; Adj EPS $2.84 (+14.1%).","R&D Solutions backlog $31.1B (+8% YoY); book-to-bill 1.22x TTM (excl. cancellation).","TAS revenue $1,554M (+8.6% YoY), accelerating from prior quarters.","FY24 guidance lowered: rev $15,350-15,400M; Adj EPS $11.10-11.20 due to two mega trial delays.","Operating cash flow YTD $1,831M (+31% YoY); FCF $1,393M (+49% YoY); $200M share buyback in Q3."],"consensus_eps_estimate":null,"consensus_eps_actual":5.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":11447000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206676,"accession_number":"0001478242-24-000090","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q2 2024 revenue $3.81B (+2.3% YoY), adj EPS $2.64, updated FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3,814M (+2.3% reported, +3.5% constant currency); GAAP net income $363M, diluted EPS $1.97.","Adjusted diluted EPS $2.64 (+8.6% YoY); Adjusted EBITDA $887M (+2.7% YoY).","R&D Solutions bookings $2.7B (book-to-bill 1.27x); backlog $30.6B (+7.7% YoY).","Full-year 2024 guidance: revenue $15,425M-$15,525M, Adj EBITDA $3,705M-$3,765M, Adj EPS $11.10-$11.30.","Q2 free cash flow $445M; net leverage ratio 3.25x trailing twelve-month Adj EBITDA."],"consensus_eps_estimate":null,"consensus_eps_actual":3.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":7551000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223868,"accession_number":"0001193125-24-136226","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-05-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"IQVIA President Kevin Knightly transitions to Senior Advisor to CEO effective May 15","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin C. Knightly steps down as President, Corporate Strategy and Enterprise Networks effective May 15, 2024.","He will become Senior Advisor to CEO; compensation commensurate with the new role.","No successor announced; transition is a planned role change."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223867,"accession_number":"0001193125-24-128463","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q1 revenue $3,737M, adj EPS $2.54; reaffirms FY guidance with FX adjustment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $1.56; adjusted EPS $2.54; adjusted EBITDA $862M (+1.3% YoY).","R&DS backlog $30.1B (+7.9% YoY); Q1 book-to-bill 1.23x (over 1.3x excl. large CNS cancellation).","Revenue +2.3% reported (+2.9% CC); TAS +0.6%, R&DS +3.4%, CSMS +3.8%.","FY 2024 revenue guidance lowered $75M for FX to $15,325M-$15,575M; adj EBITDA ($3.7B-$3.8B) and adj EPS ($10.95-$11.25) reaffirmed.","Operating cash flow $522M; free cash flow $377M; net leverage 3.38x."],"consensus_eps_estimate":null,"consensus_eps_actual":1.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":3737000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223866,"accession_number":"0001193125-24-098516","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-04-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"IQVIA stockholders elect all six director nominees, approve say-on-pay at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected all six director nominees; Sheila Stamps received 159.7M votes for, Todd Sisitsky 129.9M.","Advisory say-on-pay approved with 134.1M for, 26.1M against, 379K abstain.","Stockholder proposal on political spending rejected: 21.1M for, 138.0M against.","Ratification of PwC as auditor for 2024 passed with 152.2M for, 14.8M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243256,"accession_number":"0001157523-24-000236","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-02-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA reports Q4 revenue $3.87B, GAAP EPS $2.54; issues FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $3,868M (+3.5% YoY); GAAP net income $469M (+106.6%); adjusted EPS $2.84 (+2.2%).","Full-year 2023 revenue $14,984M (+4.0%); adjusted EBITDA $3,569M (+6.7%); adjusted diluted EPS $10.20.","R&D Solutions contracted backlog $29.7B (+9.2% YoY); Q4 book-to-bill 1.31x.","FY2024 guidance: revenue $15.4-15.65B, adjusted EBITDA $3.7-3.8B, adjusted EPS $10.95-$11.25.","Refinanced $2.75B debt to 2029/2031 at ~4.9% fixed; over 80% debt fixed. Q4 share repurchases $229M."],"consensus_eps_estimate":null,"consensus_eps_actual":7.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":14984000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}